Vanderbilt Ingram Cancer Center

Vanderbilt University Medical Center (VUMC) has been named to the Becker’s Hospital Review roster of 100 Hospitals and Health Systems with Great Oncology Programs. Read More

In her life, Jessi Zazu, 27, has toured the world as a musician in the group Those Darlins, recorded three studio albums, starred in music videos and exhibited her original artwork in individual and group art shows. Read More

Thanks to advances in treatment, the relative five-year survival rate from all combined subtypes of breast cancer now exceeds 90 percent and yet the disease remains the third leading cause of cancer deaths in the United States after lung and colorectal cancers. Read More

Using bioinformatics approaches, Vanderbilt investigators have identified gene expression networks that are deregulated in mouse and human stomach cancers. Read More

Curiosity is the spark that has always energized and illuminated Eric Shinohara’s life — curiosity about the natural world, about other people and about how to help those individuals. Read More

Research led by Vanderbilt-Ingram Cancer Center (VICC) investigators may have solved a mystery about why a targeted therapy stops working in a small group of breast cancer patients. Read More

The Nashville Sounds baseball team recently highlighted cancer care at Vanderbilt-Ingram Cancer Center (VICC) during a special “Cancer Awareness Night.” Read More

Researchers at Vanderbilt University Medical Center (VUMC) have discovered a protein that may lead to a new way to prevent resistance and improve outcomes for patients whose cancers have mutations in the tumor suppressor gene BRCA2. Read More

Carlos L. Arteaga, M.D., director of the Center for Cancer Targeted Therapies (C2T2), director of the Breast Cancer Research Program and associate director for Clinical Research at Vanderbilt-Ingram Cancer Center (VICC), has been named director of the Harold C. Simmons Comprehensive Cancer Center and associate dean of Oncology Programs at the UT Southwestern Medical Center in Dallas. Read More

Lisa Kachnic, M.D., Cornelius Vanderbilt Chair in Radiation Oncology and chair of the Department of Radiation Oncology at Vanderbilt University Medical Center (VUMC), has been named one of the “Women to Watch” in health care by Nashville Medical News. Read More

The association between tobacco use and cancer is well known. But there are other risk factors for cancer that are less recognized, including the link between cancer and certain viruses. Read More

Lauren Hackett, MPA, executive director of Administration and chief business officer for Vanderbilt-Ingram Cancer Center (VICC), has been elected to serve on the Finance Committee for the National Comprehensive Cancer Network (NCCN). Read More

A novel immunotherapy combination induced remarkable regression of tumors in a mouse model of head and neck cancer. Read More

Participating in the Downtown Derby Bed Race to benefit the T.J. Martell Foundation are, from left, Ross Oreto, Lauren Hackett, Li Wen, Clay Washburn and Tommy Hollinden. (photo by Sarah Como) Staff members from Vanderbilt-Ingram Cancer Center (VICC) garnered an impressive second place finish in last month’s Downtown Derby Bed… Read More

Los Angeles native Christina Shaw had two powerful goals when she decided to move cross country to live in Nashville – the first was to support her favorite hockey team and the second was to meet a renowned lung cancer specialist at Vanderbilt-Ingram Cancer Center. Read More

Clinical geneticist Tuya Pal, M.D., has joined Vanderbilt-Ingram Cancer Center (VICC) as associate director of Cancer Health Disparities. Pal also has been named an associate professor of Medicine and Ingram Associate Professor of Cancer Research. Read More

An international genomic data-sharing consortium has analyzed nearly 19,000 patient genomic records and found that testing of patient tumors for relevant gene mutations often provides a roadmap for the use of effective therapies. Read More

Vanderbilt-Ingram Cancer Center (VICC), in collaboration with the Hereditary Cancer Program and the Vanderbilt Breast Center, is hosting a free seminar, “Are You at High Risk for Breast Cancer?” Read More

Vanderbilt-Ingram Cancer Center (VICC), in collaboration with the Hereditary Cancer Program and the Vanderbilt Breast Center, will host a free seminar, “Are You at High Risk for Breast Cancer?” Read More

The CEO Roundtable on Cancer has re-accredited Vanderbilt University Medical Center (VUMC) as a CEO Cancer Gold Standard employer for 2017 for VUMC’s efforts to reduce the risk of cancer for employees and their families. Read More